Showing results (1021-1030 of 1,244) with videos related to
Sort By:
Pageof 125
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 14, 2022
Absolute quantification of plasma mitochondrial DNA by droplet digital PCR marks COVID-19 severity over time during intensive care unit admissionsMark L Hepokoski, Mazen Odish, Michael T Lam, et al.Antimicrobial Agents and Chemotherapy|December 19, 2025
Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerizationVincent H J Leonard, Dianna B Vidales, Benjamin R Taft, et al.Molecular Cell|September 22, 2015
SPG7 Is an Essential and Conserved Component of the Mitochondrial Permeability Transition PoreSanthanam Shanmughapriya, Sudarsan Rajan, Nicholas E Hoffman, et al.Nature|September 16, 2021
An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemnessFei Mo, Zhiya Yu, Peng Li, et al.Brain : a Journal of Neurology|December 10, 2003
The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's diseaseRina Bandopadhyay, Ann E Kingsbury, Mark R Cookson, et al.Nature|June 8, 2022
Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, Mikko Siurala, Leon L Su, et al.Science (New York, N.Y.)|June 18, 2016
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cellsGiuseppina Arbore, Erin E West, Rosanne Spolski, et al.Nature Communications|July 18, 2018
Act1 is a negative regulator in T and B cells via direct inhibition of STAT3Cun-Jin Zhang, Chenhui Wang, Meiling Jiang, et al.American Journal of Medical Genetics|October 26, 1999
Polytopic anomalies with agenesis of the lower vertebral columnA Bohring, S O Lewin, J F Reynolds, et al.Bioorganic & Medicinal Chemistry Letters|May 29, 2002
CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitorsR P Alexander, G J Warrellow, M A W Eaton, et al.Pageof 125